Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Clinical trial NCT00556959 · COMPLETED
Trial details
- NCT number
- NCT00556959
- Sponsor
- Addrenex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2008-08-01
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.